Last Week’s Hot Topic on Pulmonary Fibrosis

Last Week’s Hot Topic on Pulmonary Fibrosis

Last week’s hot topic on pulmonary fibrosis was Experimental Pulmonary Fibrosis Therapy, GR-MD-02, Granted U.S. Patent Allowance and was written by Carolina Henriques. This article is focused on Galectin Therapeutics, Inc‘s, announcement that it has received a Notice of Allowance from the U.S. Patent and Trademark Office…

Mechanism to Ease Lung Infection

Researchers reported a novel role for a receptor at the surface of macrophages (specialized cells of the immune system) in lung fibrosis resolution. The study, titled “TRPV4 Mechanosensitive Ion Channel Regulates LPS-Stimulated Macrophage Phagocytosis,” was published in the Journal of Immunology. Altogether, the results…

IPF in Untreated Patients Detected with 86% Accuracy in a Single NuQ Blood Test, Company Reports

VolitionRx recently reported preliminary results from a pilot study showing that its NuQ blood assay was capable of detecting 86 percent of relevant idiopathic pulmonary fibrosis (IPF) cases among the 78 participants of a clinical trial at Liège University Hospital. The NuQ test utilizes the company’s proprietary Nucleosomics technology platform, which identifies and measures circulating fragments…

What is COPD?

In this short video, watch “simple animation explaining what COPD is, how it is caused, the main symptoms and treatments, and the lifestyle changes that can make a big difference. We hope this video will be useful to you and those around you.” Learn more about pulmonary fibrosis…

How Can I adapt My lifestyle if I’m Living with IPF?

In this video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis, watch Dr. Toby Maher give “some positive advice on how patients with idiopathic pulmonary fibrosis (IPF) should adapt their lifestyle and better cope with this disease.” Learn more about idiopathic pulmonary fibrosis (IPF): https://bit.ly/1QiRmr3…